1-3 of 3
Authors: Timothy B Doyle
Sort by
Journal Article
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
Mariana Castanheira and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 12, December 2021, Pages 3125–3134, https://doi.org/10.1093/jac/dkab306
Published: 30 August 2021
Journal Article
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
Rodrigo E Mendes and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 2833–2838, https://doi.org/10.1093/jac/dkab279
Published: 26 August 2021
Journal Article
Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals
Mariana Castanheira and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 9, September 2019, Pages 2588–2595, https://doi.org/10.1093/jac/dkz243
Published: 21 June 2019
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals